Current HIV treatment guidelines - An overview

Keyphrases

• HIV Infection 100%
• Antiretroviral Therapy 100%
• HIV Treatment Guidelines 100%
• Clinical Practice Guidelines 50%
• Highly Active Antiretroviral Therapy (HAART) 50%
• Opportunistic Infections 50%
• Virus 50%
• Viral Replication 50%
• Antiretroviral 50%
• Pre-exposure Prophylaxis (PrEP) 50%
• Health Care Services 50%
• Pathophysiology 50%
• Hepatitis C Virus 50%
• Viral Dynamics 50%
• Tuberculosis 50%
• Immune Reconstitution 50%
• Current Therapeutics 50%
• Testing Method 50%
• Recommendations for Practice 50%
• Combination Therapy 50%
• Viral Load Monitoring 50%
• Health Departments 50%
• HIV-related 50%
• World Health Organization Recommendations 50%
• Resource-limited Settings 50%
• Infection Infection 50%
• Co-infection 50%
• Special Populations 50%
• Viral Classification 50%
• Infection-viral 50%
• Antiretroviral Agents 50%
• US Public Health Service 50%
• Cellular Entry 50%
• Therapeutic Approaches 50%
• Occupational Exposure 50%
• Treatment of HIV Infection 50%
• Human Immunodeficiency Virus Type 1 (HIV-1) 50%
• Human Services 50%
• Viral Maturation 50%
• Hepatitis B Virus 50%
• Viral Transcription 50%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Human Immunodeficiency Virus Infection 75%
• Antiretroviral Therapy 50%
• Public Health 25%
• Highly Active Antiretroviral Therapy 25%
• Opportunistic Infection 25%
• Combination Therapy 25%
• Clinician 25%
• Health Service 25%
• Hepatitis C Virus 25%
• Immune Reconstitution 25%
• Antiretrovirus Agent 25%
• Post-Exposure Prophylaxis 25%
• Mixed Infection 25%
• Maturation 25%
• Occupational Exposure 25%
• Pathophysiology 25%
• Viral Load Testing 25%
• Virus Replication 25%
• Viral Transcription 25%
• Hepatitis B Virus 25%
• Adolescence 25%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Human Immunodeficiency Virus Infection 75%
• Opportunistic Infection 25%
• Pathophysiology 25%
• Mixed Infection 25%
• Hepatitis B Virus 25%
• Antiretrovirus Agent 25%
• Occupational Exposure 25%
• Hepatitis C Virus 25%
• Combination Therapy 25%